Consensus Omega Healthcare Investors, Inc.

Equities

OHI

US6819361006

Market Closed - Nyse 04:00:01 2024-04-18 pm EDT 5-day change 1st Jan Change
29.98 USD +0.07% Intraday chart for Omega Healthcare Investors, Inc. -2.28% -2.22%

Evolution of the average Target Price on Omega Healthcare Investors, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f9fb7d8520851b93d59a4.dNinezvDMIqmmhTgn_XNeGiwXLrzEsXdo9DKRsDyrng.K6_2KWmMAsnR2EaMrrOXAR3TBY2_W7Oe8qiZdoac3RpDk5ILYrtXp-roUQ~d284d390fbafacc5ac889ad17f74aefd
Truist Securities Raises Price Target on Omega Healthcare Investors to $32 From $31, Maintains Hold Rating MT
Citigroup Upgrades Omega Healthcare Investors to Buy From Neutral, Adjusts Price Target to $35 From $32 MT
Wells Fargo Upgrades Omega Healthcare Investors to Overweight From Equalweight, Adjusts Price Target to $35 From $31 MT
BNP Paribas Exane Upgrades Omega Healthcare Investors to Neutral From Underperform, $30 Price Target MT
Deutsche Bank Initiates Coverage on Omega Healthcare Investors With Buy Rating, $36 Price Target MT
BofA Downgrades Omega Healthcare Investors to Neutral From Buy, Notes Continued Tenant Issues; Trims PT to $31 From $33 MT
Mizuho Securities Trims Omega Healthcare Investors' Price Target to $34 From $35, Keeps Buy Rating MT
Truist Securities Cuts Omega Healthcare Investors' Price Target to $31 From $34, Keeps Hold Rating MT
Wells Fargo Adjusts Price Target on Omega Healthcare Investors to $33 From $34, Maintains Equal-Weight Rating MT
BNP Paribas Exane Downgrades Omega Healthcare Investors to Underperform From Neutral MT
Wells Fargo Adjusts Price Target on Omega Healthcare Investors to $34 From $33, Maintains Equalweight Rating MT
BNP Paribas Starts Omega Healthcare Investors at Neutral Rating, $36 Price Target MT
BofA Securities Upgrades Omega Healthcare Investors to Buy From Neutral MT
Wedbush Starts Omega Healthcare Investors at Neutral With $34 Price Target MT
Raymond James Adjusts Omega Healthcare Investors' Price Target to $36 From $33, Keeps Outperform Rating MT
RBC Initiates Omega Healthcare Investors at Sector Perform With $33 Price Target, Says Stock Price Already Reflects Recovery MT
Mizuho Securities Upgrades Omega Healthcare Investors to Buy From Neutral, Adjusts Price Target to $35 From $31 MT
Wells Fargo Adjusts Omega Healthcare Investors Price Target to $33 From $32, Maintains Equal Weight Rating MT
BMO Capital Initiates Omega Healthcare Investors With Market Perform Rating, $34.50 Price Target MT
Wells Fargo Downgrades Omega Healthcare Investors to Equalweight From Overweight, Price Target is $32 MT
Truist Securities Adjusts Omega Healthcare Investors Price Target to $33 From $29, Maintains Hold Rating MT
Mizuho Securities Adjusts Omega Healthcare Investors Price Target to $31 From $32, Maintains Neutral Rating MT
Wells Fargo Adjusts Price Target on Omega Healthcare Investors to $32 From $30, Maintains Overweight Rating MT
Stifel Adjusts Omega Healthcare Investors' Price Target to $33 From $36, Keeps Buy Rating MT
Wells Fargo Initiates Omega Healthcare Investors at Overweight With $30 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
29.98 USD
Average target price
32.79 USD
Spread / Average Target
+9.36%
High Price Target
37 USD
Spread / Highest target
+23.42%
Low Price Target
28 USD
Spread / Lowest Target
-6.60%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Omega Healthcare Investors, Inc.

Truist Securities
Citigroup
Wells Fargo Securities
BNP Paribas Exane
Deutsche Bank Securities
BofA Securities
Mizuho Securities
Wedbush
Raymond James
RBC Capital Markets
BMO Capital
Stifel Nicolaus
Barclays
Baird
Scotiabank
Credit Suisse
Berenberg Bank
Jefferies & Co.
JMP Securities
Capital One Securities
Wolfe Research
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock Market
  2. Equities
  3. OHI Stock
  4. Consensus Omega Healthcare Investors, Inc.